Kmieciak D, Biernacka-Lukanty J, Migdalski P, Turek-Plewa J, Wierzbicki A, Juszczyk J, Trzeciak W H
Department of Biochemistry and Molecular Biology, Karol Marcinkowski University of Medical Sciences, 6 Swiecickiego St., 60-781 Poznań, Poland.
Acta Virol. 2005;49(2):97-103.
A correlation between the heterogeneity of hypervariable region 1 (HVR1) of E2 glycoprotein (gp) and Hepatitis C virus (HCV) antibody profile was investigated. Of 6 patients studied two were in acute phase, two in chronic phase and two showed signs of long-time HCV infection, i.e. liver cirrhosis. All the patients exhibited a vigorous antibody response to viral proteins C, NS3, NS4 and NS5. An antibody response to HVR1 of E2 was found in one patient in acute phase and in one or two patients in chronic phase. Such a response was not found in the two patients with liver cirrhosis. Single-stranded conformation polymorphism (SSCP) and sequence analyses of HVR1 of E2 showed the lowest HVR1 heterogeneity in patients in acute phase and the highest one in those in chronic phase, while the long-time carriers of the virus showed an intermediate heterogeneity. This may reflect a specific interplay between the virus and immune system. The HVR1 heterogeneity may rise in the course of infection as a means of evading the immune pressure. Then, when an organism is unable to clear the virus, because the responses to HVR1 epitopes are weakened or exhausted, a population of less heterogeneous HVR1 variants may be established.
研究了丙型肝炎病毒(HCV)E2糖蛋白(gp)高变区1(HVR1)的异质性与HCV抗体谱之间的相关性。在研究的6名患者中,2名处于急性期,2名处于慢性期,2名表现出长期HCV感染的迹象,即肝硬化。所有患者对病毒蛋白C、NS3、NS4和NS5均表现出强烈的抗体反应。在1名急性期患者和1或2名慢性期患者中发现了对E2的HVR1的抗体反应。在2名肝硬化患者中未发现这种反应。E2的HVR1的单链构象多态性(SSCP)和序列分析显示,急性期患者的HVR1异质性最低,慢性期患者的HVR1异质性最高,而病毒的长期携带者表现出中等程度的异质性。这可能反映了病毒与免疫系统之间的特定相互作用。HVR1异质性可能在感染过程中升高,作为逃避免疫压力的一种手段。然后,当机体无法清除病毒时,由于对HVR1表位的反应减弱或耗尽,可能会形成一群异质性较低的HVR1变体。